Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» zolbetuximab
zolbetuximab
Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
Drugs.com
Astellas
zolbetuximab
clinical trials
gastric cancer
Flag link:
ASCO-GI 2023 – zolbetuximab opens up a stomach cancer niche
ASCO-GI 2023 – zolbetuximab opens up a stomach cancer niche
EP Vantage
ASCO-GI
zolbetuximab
cancer of the gastro-esophageal junction
Astellas
Flag link:
Astellas’ Phase III gastric cancer therapy trial meets primary endpoint
Astellas’ Phase III gastric cancer therapy trial meets primary endpoint
Clinical Trials Arena
Astellas
clinical trials
zolbetuximab
gastric cancer
Flag link:
Astellas' $1.3B antibody strikes first in hot cancer field, extending survival in phase 3
Astellas' $1.3B antibody strikes first in hot cancer field, extending survival in phase 3
Fierce Biotech
Astellas
zolbetuximab
clinical trials
cancer
gastric cancer
Flag link:
